Rheumatology - Medtelligence

1-3 of 3

Exploring Developments in IgAN and FSGS
Exploring Developments in IgAN and FSGS
CME/CE
Exploring Developments in IgAN and FSGS
Howard Trachtman, MD, FASN; Richard Lafayette, MD, FACP
0.25 credits
- Howard Trachtman, MD, FASN
- Richard Lafayette, MD, FACP
0.25 credits
Can We Do Better in IgAN?
Can We Do Better in IgAN?
CME/CE
Can We Do Better in IgAN?
Jonathan Barratt, MD, PhD; Annette Bruchfeld, MD, PhD
- Jonathan Barratt, MD, PhD
- Annette Bruchfeld, MD, PhD
Understanding IgAN & FSGS: Pathophysiology and Emerging Therapies
Understanding IgAN & FSGS: Pathophysiology and Emerging Therapies
CME/CE
Understanding IgAN & FSGS: Pathophysiology and Emerging Therapies
Jonathan Barratt, MD, PhD; Donald E. Kohan, MD, PhD
- Jonathan Barratt, MD, PhD
- Donald E. Kohan, MD, PhD